Search research articles
Contact Us
Filters
Showing results (161-170 of 265) with videos related to
Page
of 27
Sort By:
Data in Brief
|
January 14, 2016
Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)
Arpita Basu, Alicia J Jenkins, Ying Zhang, et al.
The American Journal of Clinical Nutrition
|
February 18, 2022
French-fried potato consumption and energy balance: a randomized controlled trial
Daniel L Smith, Rebecca L Hanson, Stephanie L Dickinson, et al.
Diabetes
|
April 12, 2014
KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression
Chu-Fang Chou, Yi-Yu Lin, Hsu-Kun Wang, et al.
Diabetes, Obesity & Metabolism
|
March 14, 2025
Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme
Brandon K Bergman, Julio Rosenstock, W Timothy Garvey, et al.
Diabetes
|
November 30, 2006
Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women
Julian Munoz, Kerry H Lok, Barbara A Gower, et al.
JACC. Advances
|
May 20, 2024
Cardiometabolic Disease Staging and Major Adverse Cardiovascular Event Prediction in 2 Prospective Cohorts
Carrie R Howell, Li Zhang, Tapan Mehta, et al.
Atherosclerosis
|
July 27, 2014
Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study
Arpita Basu, Alicia J Jenkins, Julie A Stoner, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
December 10, 2009
Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance
Jiarong Liu, Xuxia Wu, John L Franklin, et al.
Diabetes, Obesity & Metabolism
|
October 6, 2022
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses
Mikhail N Kosiborod, Meena Bhatta, Melanie Davies, et al.
Lancet (London, England)
|
June 29, 2023
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Filip K Knop, Vanita R Aroda, Ruben D do Vale, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 265) with videos related to
Sort By:
Page
of 27
Data in Brief
|
January 14, 2016
Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)
Arpita Basu, Alicia J Jenkins, Ying Zhang, et al.
The American Journal of Clinical Nutrition
|
February 18, 2022
French-fried potato consumption and energy balance: a randomized controlled trial
Daniel L Smith, Rebecca L Hanson, Stephanie L Dickinson, et al.
Diabetes
|
April 12, 2014
KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression
Chu-Fang Chou, Yi-Yu Lin, Hsu-Kun Wang, et al.
Diabetes, Obesity & Metabolism
|
March 14, 2025
Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme
Brandon K Bergman, Julio Rosenstock, W Timothy Garvey, et al.
Diabetes
|
November 30, 2006
Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women
Julian Munoz, Kerry H Lok, Barbara A Gower, et al.
JACC. Advances
|
May 20, 2024
Cardiometabolic Disease Staging and Major Adverse Cardiovascular Event Prediction in 2 Prospective Cohorts
Carrie R Howell, Li Zhang, Tapan Mehta, et al.
Atherosclerosis
|
July 27, 2014
Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study
Arpita Basu, Alicia J Jenkins, Julie A Stoner, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
December 10, 2009
Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance
Jiarong Liu, Xuxia Wu, John L Franklin, et al.
Diabetes, Obesity & Metabolism
|
October 6, 2022
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses
Mikhail N Kosiborod, Meena Bhatta, Melanie Davies, et al.
Lancet (London, England)
|
June 29, 2023
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Filip K Knop, Vanita R Aroda, Ruben D do Vale, et al.
Page
of 27